Fig. 8From: FOXD3 may be a new cellular target biomarker as a hypermethylation gene in human ovarian cancerRestored expression of FOXD3 inhibits the growth of xenograft tumors. a Over-expression FOXD3 group and 5-Aza-dC group showed significantly smaller tumors. b–d Over-expression FOXD3 group and 5-Aza-dC group showed obvious inhibition on tumor volume and tumor weight compared with control groups in SKOV3 and OV90 cell lines. e Over-expression FOXD3 group and 5-Aza-dC group showed significantly lower expression level of FOXD3 in tumors, *p < 0.05, **p < 0.01Back to article page